Atlas Venture Fund X, LP Sells Common Stock in Disc Medicine, Inc.

Atlas Venture Fund X, LP has filed a notice of sale of 22,160 shares of common stock in Disc Medicine, Inc., acquired through a private placement on May 1, 2020. The sale is expected to occur on October 15, 2025, with an aggregate market value of $1,617,680. Additionally, the filing details multiple transactions over the past three months, where Atlas Venture Fund X, LP and its affiliate, Atlas Venture Opportunity Fund I, LP, sold significant amounts of common stock, totaling millions of dollars. The transactions were executed through Merrill Lynch on the Nasdaq exchange. This filing highlights substantial divestment activity by Atlas Venture in Disc Medicine, Inc.